# Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension

> **NCT00709098** · PHASE3 · COMPLETED · sponsor: **Actelion** · enrollment: 49 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** iloprost
- **DRUG:** iloprost

## Key facts

- **NCT ID:** NCT00709098
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709098, "Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00709098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*